Literature DB >> 17077539

Particulate and microbial contamination in in-use admixed intravenous infusions.

Katsuhiro Yorioka1, Shigeharu Oie, Masafumi Oomaki, Akihisa Imamura, Akira Kamiya.   

Abstract

We compared particulate and microbial contamination in residual solutions of peripheral intravenous admixtures after the termination of drip infusion between intravenous fluids admixed with glass ampoule drugs and those admixed with pre-filled syringe drugs. The mean number of particles>or=1.3 microm in diameter per 1 ml of residual solution was 758.4 for fluids (n=60) admixed with potassium chloride in a glass ampoule (20 ml volume), 158.6 for fluids (n=63) admixed with potassium chloride in a pre-filled syringe (20 ml volume), 736.5 for fluids (n=66) admixed with sodium chloride in a glass ampoule (20 ml volume), 179.2 for fluids (n=15) admixed with sodium chloride in a pre-filled syringe (20 ml volume), 1884.5 in fluids (n=30) admixed with dobutamine hydrochloride in 3 glass ampoules (5 ml volume), and 178.9 (n=10) in diluted dobutamine hydrochloride in pre-filled syringes (50 ml volume: For these samples alone, particulate and microbial contamination were evaluated in sealed products.) Thus, for potassium chloride or sodium chloride for injection, the number of particles>or=1.3 microm in diameter in the residual intravenous solution was significantly higher for fluids admixed with glass ampoule drugs than for those admixed with pre-filled syringe drugs (p<0.0001). For dobutamine hydrochloride for injection, the number of particles>or=1.3 microm in diameter in the residual intravenous solution was estimated to be higher for fluids admixed with its glass ampoule drug than for those admixed with its pre-filled syringe drug. Observation of the residual solutions of fluids admixed with potassium chloride, sodium chloride, or dobutamine hydrochloride in glass ampoules using an electron microscope with an X-ray analyzer showed glass fragments in each residual solution. Therefore, for the prevention of glass particle contamination in peripheral intravenous admixtures, the use of pre-filled syringe drugs may a useful method. No microbial contamination was observed in any of the residual solutions of 5 types of admixture.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077539     DOI: 10.1248/bpb.29.2321

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

1.  Intubation drug pack containing pre-filled syringes reduces the time to endotracheal intubation in a simulated paediatric emergency.

Authors:  Sara Lawson; Christopher Flannigan; Carolyn Green; Lynsey Freeburn; Anne Burns; Joseph McCann; Thomas Bourke
Journal:  BMJ Simul Technol Enhanc Learn       Date:  2020-03-02

2.  Analysis of particulate contaminations of infusion solutions in a pediatric intensive care unit.

Authors:  Thomas Jack; Bernadette E Brent; Martin Boehne; Meike Müller; Katherina Sewald; Armin Braun; Armin Wessel; Michael Sasse
Journal:  Intensive Care Med       Date:  2010-02-18       Impact factor: 17.440

3.  Particulate contamination in intravenous drugs: coring from syringe plunger.

Authors:  S K Singhal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2010-10

4.  The effect of different methods of intravenous injection on glass particle contamination from ampules.

Authors:  Ga Eul Joo; Kyeong-Yae Sohng; Michael Yong Park
Journal:  Springerplus       Date:  2016-01-06

5.  Fibrin Clot Mistook as a Worm in the Intravenous Line.

Authors:  Jun Hyun Kim; Ji Yeon Kim; Yeon Soo Park; Kyung Tae Kim; Sang Il Lee; Min Hee Heo
Journal:  Yonsei Med J       Date:  2020-03       Impact factor: 2.759

6.  In-line filtration minimizes organ dysfunction: new aspects from a prospective, randomized, controlled trial.

Authors:  Martin Boehne; Thomas Jack; Harald Köditz; Kathrin Seidemann; Florian Schmidt; Michaela Abura; Harald Bertram; Michael Sasse
Journal:  BMC Pediatr       Date:  2013-02-06       Impact factor: 2.125

7.  Influence of in-line microfilters on systemic inflammation in adult critically ill patients: a prospective, randomized, controlled open-label trial.

Authors:  Ilse Gradwohl-Matis; Andreas Brunauer; Daniel Dankl; Elisabeth Wirthel; Ingeborg Meburger; Angela Bayer; Michaela Mandl; Martin W Dünser; Wilhelm Grander
Journal:  Ann Intensive Care       Date:  2015-11-04       Impact factor: 6.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.